Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE study of eplerenone added to lisinopril with normal versus sodium-restricted diet in diabetic nephropathy
NL-OMON27384Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of eplerenone, lisinopril and hydrochlorothiazide in diabetic glomerulosclerosis and hypertension (HTN) (4 arms), sponsored by University Medical Center Groningen. Primary endpoints: Albuminuria and Blood pressure. Planned start Feb 2010; status: not yet recruiting.
02
Drugs
eplerenonelisinoprilhydrochlorothiazide
03
Conditions
diabetic glomerulosclerosishypertension (HTN)
Beyond the preview
Go deeper on NL-OMON27384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27384.